Publicacións nas que colabora con Rosario Palacios Muñoz (15)

2021

  1. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?

    International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260

  2. Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain

    HIV Medicine, Vol. 22, Núm. 5, pp. 379-386

  3. Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response

    AIDS (London, England), Vol. 35, Núm. 13, pp. 2119-2127

  4. Progression to hepatitis C virus micro-elimination in people living with HIV in Spain

    Clinical Microbiology and Infection

2020

  1. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 71, Núm. 9, pp. 2354-2362

  2. Using machine learning methods to determine a typology of patients with HIVHCV infection to be treated with antivirals

    PLoS ONE, Vol. 15, Núm. 1

  3. What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: A modeling analysis

    BMC Infectious Diseases, Vol. 20, Núm. 1

2019

  1. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients

    Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 48-54

  2. Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR

    Scientific Reports, Vol. 9, Núm. 1

  3. Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks

    Journal of Infection, Vol. 79, Núm. 1, pp. 30-35

  4. Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy

    Journal of Hepatology, Vol. 71, Núm. 1, pp. 45-51

  5. Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection

    Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 16-24

2018

  1. Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice

    HIV Clinical Trials, Vol. 19, Núm. 1, pp. 23-30

  2. Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 9, pp. 2435-2443

2016

  1. Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 357-361